Jeffrey Alan Jones - 18 Dec 2025 Form 4 Insider Report for Cullinan Therapeutics, Inc. (CGEM)

Role
Chief Medical Officer
Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact
Issuer symbol
CGEM
Transactions as of
18 Dec 2025
Net transactions value
-$44,791
Form type
4
Filing time
19 Dec 2025, 17:00:14 UTC
Previous filing
27 Feb 2025
Next filing
19 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Jones Jeffrey Alan Chief Medical Officer C/O CULLINAN THERAPEUTICS, INC., ONE MAIN STREET, SUITE 1350, CAMBRIDGE /s/ Jacquelyn Sumer, Attorney-in-Fact 19 Dec 2025 0001914647

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGEM Common Stock Sale $44,791 -4,632 -2.7% $9.67 169,532 18 Dec 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.